READ-IT

  • Learning and Monitoring Zone

Search

  • Home
  • About READ-It
    • READ-It Partners
    • Key achievements
    • READ-It impact posters
    • READ-It Management Office
  • Publications & Multimedia
    • READ-It annual reports
    • Resources
    • Guidelines
    • Multimedia resources
    • Other publications and stories
  • Cochrane reviews
    • Cochrane Reviews: COVID-19
    • Cochrane Reviews: Other topics
    • Cochrane Reviews: Maternal and child health
    • Cochrane Reviews: Neglected tropical diseases
    • Cochrane Reviews: HIV/AIDS
    • Cochrane Reviews: Tuberculosis
    • Cochrane Reviews: Diarrhoea
    • Cochrane Reviews: Malaria
  • News & Events
HomeCochrane reviewsCochrane Reviews: Tuberculosis

Cochrane Reviews on tuberculosis by the READ-It team

Cochrane Reviews: Tuberculosis

0
23 Mar 2021

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.

How accurate are sputum Xpert tests for screening for active pulmonary tuberculosis and rifampicin resistance in adults whether or not they have tuberculosis symptoms?

Cochrane Systematic Review: NEW
22 Feb 2021

Update: Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

Why is improving the diagnosis of pulmonary tuberculosis important?

Cochrane Systematic Review: UPDATE
15 Jan 2021

Update: Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults

How accurate are tests (Xpert Ultra and Xpert MTB/RIF) for diagnosing tuberculosis outside the lungs (extrapulmonary tuberculosis) and rifampicin resistance?

Cochrane Systematic Review: UPDATE
27 Aug 2020

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children

The aim of this review is to determine the accuracy of tests in symptomatic children for diagnosing pulmonary tuberculosis, tuberculous meningitis, lymph node tuberculosis, and rifampicin resistance.

Cochrane Systematic Review: NEW
  • ‹ previous
  • 3 of 6
  • next ›

Follow us

  • Facebook
  • Twitter

READ-It (project number 300342-104) is funded by the Foreign, Commonwealth and Development Office (FCDO)

  • Privacy
  • Disclaimer
A Remora website by Manta Ray Media